Navigation Links
Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
Date:1/3/2008

RESEARCH TRIANGLE PARK, N.C., Jan. 3 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that Neil Frazer, M.B., Ch.B., FRCA, FFPM has joined the company as Chief Medical Officer.

Prior to joining Chimerix, Dr. Frazer served as the Chief Medical Officer and Chief Operating Officer of Erimos Pharmaceuticals (previously Biocure Medical) where he was responsible for the design of clinical drug development programs to meet U.S. and global commercial, regulatory and scientific objectives. Prior to his tenure at Erimos, Dr. Frazer served as the Vice President, Clinical Research at Shire Pharmaceuticals where he was responsible for clinical drug development of key programs that included Adderall XR, Equetro and Fosrenol. Dr. Frazer has also held research and development positions at Pharmalink FHI, Medicab, Inc., TabSafe Medical Services, Inc., ClinTrials Research Inc. and Glaxo Wellcome, Inc. Dr. Frazer obtained his B.Sc. and medical degree from the University of Edinburgh Medical School.

"Dr. Frazer's years of research and development experience will be invaluable as we continue to advance our pipeline of orally available and topical antiviral agents through the clinical development process," said Dr. George Painter, Chimerix' President and CEO. "In addition to Dr. Frazer, we have also made a number of key hires in our research and development department, while maintaining our virtual research and development operating model to maintain maximum flexibility and cash efficiency."

With the addition of the new staff, Chimerix currently has 16 full-time employees. To accommodate the new employees, Chimerix has moved its headquarters to 2505 Meridian Parkway, Durham, NC 27713.

About Chimerix

Chimerix, Inc. discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...wire-FirstCall/ -- ExonHit Therapeutics S.A.,(Alt...mpany, is pleased to,announce today that it has b...ndustrial Property) during the last edition of its..., "Since its inception, ExonHit consistently...e of its intellectual property and in particular f...
(Date:12/3/2008)...dangers of first- and secondhand smoke, an estimat...mokers. Exposure of a developing baby to harmful ...s an estimated 420,000 newborns each year and pose...e first study of its kind, a team of researchers h...lical cord blood to better understand the fetal he...
(Date:12/3/2008)...ne Product Agreement Executed to Support ConjuChem...and BAGSVAERD, Denmark, Dec. 3 /PRNewswire-FirstCa... Novozymes Biopharma UK Ltd., a subsidiary of Novo...nies have entered into a long-term Manufacturing a...ill exclusively supply its recombinant human album...
(Date:12/3/2008)...wire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL )...eading producer of single-wall,carbon nanotubes, ... under,which Sigma-Aldrich will distribute SWeNT,...d development community. , Under the terms ...distribute research quantities of SWeNT(R) CG 100,...
Breaking Biology Technology:ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes 2Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes 3
..., , , , , , Multiporator / ..., , , , Transfo...15.540 07/2002 , , , , ,... , Microorganism , Pedioco... type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.526 01/2002 , , , , ,... , Microorganism , Nocardi...ll type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.525 01/2002 , , , , ,... , Microorganism , Nocardi...ell type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.519 12/2001 , , , , ,... , Microorganism , Lactoco... Cell type , Bacteria, gram positiv...
Other Biology Technology:Pediococcus spp. 2Nocardia corallina 2Nocardia asteroides 2Lactococcus lactis 2
(Date:12/4/2008)... Wake Forest University,s School of Biomedical Eng...ics has received the Army Modeling and Simulation ...f of Staff of the Army and Director of the Army pr...ly help save eyesight and reduce morbidity and mor...ter was selected from 57 applicants from around th...
(Date:12/4/2008)...ant,s defences and causes disease,by sneakily di...,revealed in new research out today (4 December) ...on a pathogen which causes bacterial speck disease... black lesions on leaves,and fruit. Severe infect...to crops, and researchers believe that understandi...
(Date:12/4/2008)... with higher levels of omega-3 fatty acids in plas...of the European study IMMIDIET that will be publis...of Clinical Nutriti on, an official publication of... available on line ( www.ajcn.org ). The study su...drinks. This effect could be ascribed to compounds...
(Date:12/4/2008)...o monitor deforestation and degradation in tropica... and Betty Moore Foundation has awarded the Carneg... a $1.6-million grant to expand and improve CLASLi...new, user-friendly method that enables even the sm...ons (NGOs) to map tropical forests from their desk...
Breaking Biology News(10 mins):New dummy design and development wins US Department of Defense award 2Red alert! How disease disables tomato plant's 'intruder alarm' 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3Tropical forest carbon monitoring gets big boost 2Senator Dean Barkley Pledges Action on HIV AIDS Epidemic 28008 1Senator Dean Barkley Pledges Action on HIV AIDS Epidemic 28008 2Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 1Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 2Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 3Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 4Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 5Animal Health International Inc Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information 28004 1Elaborate Network Drives When and Where Proteins Are Made 28003 1Elaborate Network Drives When and Where Proteins Are Made 28003 2
...olecule and snake venom may provide researchers wi...ases and developing new drugs. , Purdue University...a dendrimer, with a glowing identification tag tha...om cells from a rattlesnake. The scientists want t...centration and function of proteins involved in di...
...ity of Wisconsin School of Medicine and Public Hea...try taking part in a novel clinical trial investig...rm of severe coronary artery disease. , The trial,...lling subjects in the Autologous Cellular Therapy .... The first patient underwent the procedure March ...
...1st issue of G&D, Drs. Yong Sun Lee and Anindy...s tumor suppressors in vitro. , "Overexpression o...important tumors like uterine fibroids,?explains D...roRNAs have an important role in suppressing the o...the causation and perhaps the cure of a disease th...
...mals, males advertise to potential mates with show... levels. However, a new study suggests that, in fi...rations to be more susceptible to pathogens. , In ... a new study by Judith Mank (Uppsala University, ...howy traits ?such as bright colors or long tails a...
Other Biology News:Scientists use nanoparticle to discover disease-causing proteins 2UW launches study testing adult stem cells for heart damage repair 2UW launches study testing adult stem cells for heart damage repair 3
...ays are preactivated with carbonyl diimidazole che... groups. The PS10 array contains the same binding ...ated hydrophobic barrier coating. These arrays are...ompatible with one column of a standard 96-well mi...
Silver Stain Kit from Bio-Rad
ECM 630 Electroporation System from BTX
SILVER SEQUENCE Staining Reagents from Promega
Biology Products: